Ulixacaltamide

Name: Ulixacaltamide in Essential tremor: Generic, brand name and therapeutic class of product
Published: 2026-09-14T15:39:06-04:00

Essential tremor

Manufacturer: Praxis Precision Medicines
Regulatory submission: NDA submitted by February 2026
Launch: Not announced
Last updated: September 19, 2026

Section

Product information and disease description Product description Product information

Generic, brand name and therapeutic class of product

3 evidence topics · 3 sources

Manufacturer and investigational product name

Type of information	Source quotation
Manufacturer name	“Praxis Precision Medicines”
Unapproved product name	“Ulixacaltamide HCl”

Manufacturer: Praxis Precision Medicines

“The FDA has accepted Praxis’ NDA for ulixacaltamide for the treatment of ET” (opens the source at this quote in a new tab)

Therapeutic class

“PRAX-944 is an orally active, small molecule that belongs to the class of T-type Ca2+-channel blockers.” (opens the source at this quote in a new tab)

Confirmed commercial brand name

No evidence found.